CEM: Uses, Side Effects & Warnings

Key Takeaways

• CEM uses a contrast agent injected intravenously to highlight areas of abnormal blood flow in breast tissue, improving diagnostic accuracy.
• It is particularly useful for women with dense breast tissue or those at elevated risk for breast cancer.
• Side effects range from mild reactions such as nausea to rare but serious allergic responses to the contrast agent.
• Certain groups—including pregnant women and individuals with kidney disease—should avoid or use CEM with caution.
• The procedure closely resembles a standard mammogram and typically takes 20 to 30 minutes to complete.

What Is Contrast Enhanced Mammography (CEM) and How Is It Used?

Contrast enhanced mammography refers to a specialized imaging procedure in which an iodinated contrast agent is administered intravenously before obtaining low- and high-energy mammographic images. The contrast agent accumulates preferentially in areas with increased blood vessel activity—a hallmark of many malignant tumors—allowing radiologists to identify lesions that might be missed on standard mammography. The result is a dual-image set that highlights suspicious areas while retaining the anatomical detail of conventional X-ray mammography.

CEM is used primarily in clinical settings where conventional mammography or ultrasound provides inconclusive results. It is increasingly recommended for women with dense breast tissue, because dense tissue can obscure tumors on standard images. Studies published in peer-reviewed radiology journals have shown CEM to achieve sensitivity rates comparable to breast MRI—often cited above 90%—making it a compelling alternative, particularly in centers where MRI resources are limited or where patients cannot tolerate MRI due to claustrophobia or implanted devices.

Beyond initial diagnosis, CEM plays a meaningful role in surgical planning, monitoring treatment response in patients undergoing neoadjuvant chemotherapy, and evaluating newly diagnosed breast cancer for additional lesion extent. It is also employed as a problem-solving tool when other imaging modalities yield ambiguous findings. According to the American College of Radiology, CEM is an appropriate supplemental screening option for high-risk patients, further expanding its clinical utility beyond diagnostic contexts.

Common and Serious Side Effects of CEM

The contrast enhanced mammography side effects patients may experience are primarily related to the iodinated contrast agent rather than the mammographic imaging itself. Most reactions are mild and transient. Patients frequently report a warm sensation throughout the body, a metallic taste in the mouth, or mild nausea immediately following injection. These effects typically resolve within minutes and do not require medical intervention.

More moderate reactions can include hives, itching, and mild swelling at the injection site. Vomiting and headache occur less frequently but should be reported to the imaging team immediately. Imaging centers administer CEM under medical supervision precisely to monitor for these reactions and to intervene promptly if symptoms escalate. Patients with a prior history of contrast reactions face a higher likelihood of experiencing these moderate effects and should disclose this history before the procedure.

Serious allergic reactions, while rare, represent the most significant safety concern associated with CEM. Anaphylaxis—a severe, life-threatening hypersensitivity response—can cause difficulty breathing, a sudden drop in blood pressure, and loss of consciousness. The incidence of severe reactions to iodinated contrast media is estimated at fewer than 1 in 1,000 injections, according to published radiology safety data. Nonetheless, emergency resuscitation equipment must be available in every suite where CEM is performed. A separate concern involves contrast-induced nephropathy, a temporary decline in kidney function that can follow contrast agent administration in susceptible individuals.

Reaction Type	Common Examples	Approximate Frequency
Mild	Warm sensation, metallic taste, mild nausea	Up to 15% of patients
Moderate	Hives, vomiting, swelling at injection site	1–3% of patients
Severe	Anaphylaxis, severe bronchospasm	<0.1% of patients
Delayed	Rash, flu-like symptoms (appearing hours later)	1–2% of patients

Delayed reactions—appearing anywhere from one hour to several days after the procedure—are also documented with iodinated agents. These typically manifest as a skin rash or flu-like symptoms and are generally self-limiting. Patients should be counseled to contact their healthcare provider if any new symptoms emerge in the days following the procedure.

CEM Safety: Risks, Warnings, and Who Should Avoid It

CEM mammography risks extend beyond contrast reactions and include the radiation dose associated with the dual-energy imaging technique. Because CEM acquires both low- and high-energy images, the total radiation dose is modestly higher than that of a standard two-view mammogram. Regulatory bodies and radiology societies consider this dose clinically acceptable given the diagnostic benefit, but it remains an important factor in patient counseling, particularly for younger women and those requiring repeated imaging over time.

Contrast enhanced mammography safety and precautions require a thorough patient assessment before scheduling the procedure. Clinicians must review kidney function through serum creatinine or estimated glomerular filtration rate (eGFR) tests, as patients with moderate-to-severe chronic kidney disease face a meaningful risk of contrast-induced kidney injury. Individuals on metformin—a common diabetes medication—may also need to pause their medication around the time of contrast administration, in line with established radiology guidelines, to reduce the risk of lactic acidosis in the event of renal impairment.

Thyroid function is another consideration. Iodinated contrast agents can trigger thyroid dysfunction, particularly in patients with preexisting hyperthyroidism or those taking certain thyroid medications. Endocrinology consultation may be warranted before proceeding in these cases. Additionally, breastfeeding mothers are generally advised to discard breast milk for 24 hours following contrast administration, although current evidence suggests the actual risk of infant exposure through breast milk is very low.

Certain patient groups should either avoid CEM entirely or proceed only under carefully managed conditions:

• Pregnant women, due to both radiation exposure and the unknown effects of iodinated contrast on the fetus
• Patients with a known severe allergy to iodinated contrast agents, unless premedication protocols are implemented
• Individuals with advanced chronic kidney disease (eGFR below 30 mL/min/1.73 m²)
• Patients with uncontrolled hyperthyroidism or active thyroid disease requiring iodine-sensitive management
• Individuals who have experienced prior anaphylaxis to any contrast media

When the clinical benefit clearly outweighs the risk—such as in urgent cancer workup—physicians may proceed with appropriate premedication, hydration protocols, and close monitoring in place. The decision is always individualized and made in consultation between the patient and their clinical team.

What to Expect During a Contrast Enhanced Mammography Procedure

CEM breast imaging follows a structured protocol that begins before the patient even enters the mammography suite. At the time of scheduling, patients are typically asked about allergies, kidney function, current medications, and pregnancy status. On the day of the procedure, a nurse or technologist will insert an intravenous line, usually in the antecubital vein of the arm, through which the contrast agent will be delivered. The entire appointment generally lasts between 20 and 30 minutes.

After the contrast is injected, there is a brief waiting period—usually about two minutes—to allow the agent to circulate and accumulate within breast tissue before imaging begins. The mammographic compression and positioning steps are identical to those of a standard mammogram. Each breast is imaged in at least two views, and the dual-energy acquisition happens automatically within the same compression cycle, minimizing patient discomfort and the need for repeated compressions.

Patients should feel free to inform the technologist immediately if they experience any unusual sensations during or after the injection, including shortness of breath, skin itching, or dizziness. A radiology nurse or technologist remains in close proximity throughout the exam. After imaging is complete, patients are typically monitored briefly before leaving the facility. Results are interpreted by a board-certified radiologist and communicated to the referring clinician, usually within one to two business days, depending on the facility’s workflow.

Frequently Asked Questions

Is CEM better than a standard mammogram for detecting breast cancer?

CEM generally offers higher sensitivity than standard mammography, particularly in women with dense breast tissue. Research suggests its diagnostic performance is comparable to breast MRI in many clinical scenarios. However, it involves a contrast injection and a slightly higher radiation dose, so the decision to use CEM over standard mammography depends on individual risk factors, clinical indication, and physician recommendation rather than a universal preference.

How long do CEM side effects typically last?

Most side effects—such as the warm sensation, metallic taste, or mild nausea—resolve within minutes of the injection. Moderate reactions like hives may persist for a few hours and can be managed with antihistamines. Delayed reactions, including mild skin rashes, may appear within one to two days and usually resolve on their own. Severe reactions are rare but require immediate medical attention and may necessitate treatment in a clinical setting.

Can CEM be performed if a patient has implants or a pacemaker?

Unlike MRI, CEM is generally safe for patients with pacemakers, cochlear implants, or other metal-containing devices, since it uses X-ray technology rather than magnetic fields. Breast implants do not prevent CEM from being performed, though they may affect image acquisition technique. Patients with implants should inform the technologist in advance so that appropriate positioning and additional views can be arranged to ensure adequate visualization of breast tissue.